Keith Chervenak

1.4k total citations
26 papers, 1.1k citations indexed

About

Keith Chervenak is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Keith Chervenak has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Keith Chervenak's work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (10 papers) and Immune Cell Function and Interaction (7 papers). Keith Chervenak is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (10 papers) and Immune Cell Function and Interaction (7 papers). Keith Chervenak collaborates with scholars based in United States, Uganda and South Africa. Keith Chervenak's co-authors include W. Henry Boom, Jerrold J. Ellner, Diane V. Havlir, Robert S. Wallis, Christine Ziebold, David H. Canaday, Clifford V. Harding, Erika H. Noss, T M Daniel and Catherine M. Stein and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Keith Chervenak

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Chervenak United States	17	748	614	561	159	137	26	1.1k
Azra Blazevic United States	13	524 0.7×	845 1.4×	507 0.9×	156 1.0×	69 0.5×	26	1.2k
Bernard Landry United Kingdom	11	963 1.3×	712 1.2×	556 1.0×	199 1.3×	145 1.1×	16	1.2k
Joshua S. Woodworth United States	19	960 1.3×	873 1.4×	599 1.1×	330 2.1×	111 0.8×	22	1.4k
Megan Null United States	12	368 0.5×	712 1.2×	369 0.7×	161 1.0×	97 0.7×	18	986
Jia Yao Phuah United States	11	783 1.0×	627 1.0×	571 1.0×	197 1.2×	220 1.6×	14	1.2k
Carolyn Bigbee United States	7	778 1.0×	407 0.7×	516 0.9×	182 1.1×	250 1.8×	10	1.0k
Sebastian Gelderbloem South Africa	14	1.2k 1.7×	1.1k 1.8×	683 1.2×	203 1.3×	209 1.5×	17	1.7k
Pauline Maiello United States	19	1.1k 1.4×	507 0.8×	704 1.3×	253 1.6×	380 2.8×	45	1.4k
Anthony M. Cadena United States	9	711 1.0×	280 0.5×	480 0.9×	202 1.3×	247 1.8×	11	926
Meghan Cansler United States	11	347 0.5×	746 1.2×	340 0.6×	170 1.1×	65 0.5×	14	990

Countries citing papers authored by Keith Chervenak

Since Specialization

Citations

This map shows the geographic impact of Keith Chervenak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Chervenak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Chervenak more than expected).

Fields of papers citing papers by Keith Chervenak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Chervenak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Chervenak. The network helps show where Keith Chervenak may publish in the future.

Co-authorship network of co-authors of Keith Chervenak

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Chervenak. A scholar is included among the top collaborators of Keith Chervenak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Chervenak. Keith Chervenak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thiel, Bonnie, et al.. (2025). Evaluation of QuantiFERON TB gold plus among TB household contacts in high incidence settings. BMC Infectious Diseases. 25(1). 447–447. 1 indexed citations

Nankya, Immaculate, Joy Baseke, Dane Winner, et al.. (2022). Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda. Retrovirology. 19(1). 1–1. 8 indexed citations

Stein, Catherine M., Penelope Benchek, Jacquelaine Bartlett, et al.. (2021). Methylome-wide Analysis Reveals Epigenetic Marks Associated With Resistance to Tuberculosis in Human Immunodeficiency Virus–Infected Individuals From East Africa. The Journal of Infectious Diseases. 224(4). 695–704. 1 indexed citations

Thiel, Bonnie, William Worodria, Mary Nsereko, et al.. (2021). Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection. PLoS ONE. 16(4). e0249477–e0249477. 4 indexed citations

Stein, Catherine M., Mary Nsereko, LaShaunda L. Malone, et al.. (2018). Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda. Clinical Infectious Diseases. 68(10). 1705–1712. 42 indexed citations

Sobota, Rafal S., Catherine M. Stein, Nuri Kodaman, et al.. (2017). A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa. PLoS Genetics. 13(6). e1006710–e1006710. 19 indexed citations

Harausz, Elizabeth, Keith Chervenak, Caryn E. Good, et al.. (2016). Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture. Tuberculosis. 98. 92–96. 16 indexed citations

Hall, Noémi B., Robert P. Igo, Barbara Truitt, et al.. (2014). Polymorphisms in TICAM2 and IL1B are associated with TB. Genes and Immunity. 16(2). 127–133. 43 indexed citations

Johnson, Denise F., LaShaunda L. Malone, Sarah Zalwango, et al.. (2014). Tuberculin Skin Test Reversion following Isoniazid Preventive Therapy Reflects Diversity of Immune Response to Primary Mycobacterium tuberculosis Infection. PLoS ONE. 9(5). e96613–e96613. 13 indexed citations

10.

Tao, Liyuan, et al.. (2013). Genetic and Shared Environmental Influences on Interferon-γ Production in Response to Mycobacterium tuberculosis Antigens in a Ugandan Population. American Journal of Tropical Medicine and Hygiene. 89(1). 169–173. 20 indexed citations

11.

Mahan, Charles S., Bonnie Thiel, Keith Chervenak, et al.. (2012). Innate and Adaptive Immune Responses during Acute M. tuberculosis Infection in Adult Household Contacts in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene. 86(4). 690–697. 33 indexed citations

12.

Lancioni, Christina, Charles S. Mahan, Denise F. Johnson, et al.. (2011). Effects of Antiretroviral Therapy on Immune Function of HIV-infected Adults with Pulmonary Tuberculosis and CD4+ >350 Cells/mm3. The Journal of Infectious Diseases. 203(7). 992–1001. 13 indexed citations

13.

Stein, Catherine M., Sarah Zalwango, Allan Chiunda, et al.. (2007). Linkage and association analysis of candidate genes for TB and TNFα cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes. Human Genetics. 121(6). 663–673. 54 indexed citations

14.

Rojas, Roxana E., Keith Chervenak, Sarah Zalwango, et al.. (2005). Vδ2⁺γδ T Cell Function inMycobacterium tuberculosis–and HIV‐1–Positive Patients in the United States and Uganda: Application of a Whole‐Blood Assay. The Journal of Infectious Diseases. 192(10). 1806–1814. 15 indexed citations

15.

Havlir, Diane V., Francesca J. Torriani, Rachel Schrier, et al.. (2001). Serum Interleukin-6 (IL-6), IL-10, Tumor Necrosis Factor (TNF) Alpha, Soluble Type II TNF Receptor, and Transforming Growth Factor Beta Levels in Human Immunodeficiency Virus Type 1-Infected Individuals withMycobacterium aviumComplex Disease. Journal of Clinical Microbiology. 39(1). 298–303. 26 indexed citations

16.

Havlir, Diane V., et al.. (2000). Effect of Potent Antiretroviral Therapy on Immune Responses toMycobacterium aviumin Human Immunodeficiency Virus–Infected Subjects. The Journal of Infectious Diseases. 182(6). 1658–1663. 42 indexed citations

17.

Canaday, David H., Christine Ziebold, Erika H. Noss, et al.. (1999). Activation of Human CD8+ αβ TCR+ Cells by Mycobacterium tuberculosis Via an Alternate Class I MHC Antigen-Processing Pathway. The Journal of Immunology. 162(1). 372–379. 81 indexed citations

18.

Chervenak, Keith, Michael M. Lederman, & W. Henry Boom. (1997). Bacterial Antigen Activation of V 1 and V 2 T Cells of Persons Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 175(2). 429–433. 5 indexed citations

19.

Havlir, Diane V., Jerrold J. Ellner, Keith Chervenak, & W. Henry Boom. (1991). Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis.. Journal of Clinical Investigation. 87(2). 729–733. 121 indexed citations

20.

Boom, W. Henry, Robert S. Wallis, & Keith Chervenak. (1991). Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infection and Immunity. 59(8). 2737–2743. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact